The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B

被引：5
|
作者：
Dienstag, JL
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Med Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2004.12.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：158 / 162
页数：5
相关论文
共 50 条
  • [31] Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B
    Arrese, Elisabete
    Basaras, Miren
    Blanco, Sonia
    Ruiz, Pablo
    Cisterna, Ramon
    ANNALS OF HEPATOLOGY, 2011, 10 (04) : 434 - 440
  • [32] Flares during long-term entecavir therapy in chronic hepatitis B
    Chi, Heng
    Arends, Pauline
    Reijnders, Jurrien G. P.
    Carey, Ivana
    Brown, Ashley
    Fasano, Massimo
    Mutimer, David
    Deterding, Katja
    Oo, Ye H.
    Petersen, Jorg
    van Bommel, Florian
    de Knegt, Robert J.
    Santantonio, Teresa A.
    Berg, Thomas
    Welzel, Tania M.
    Wedemeyer, Heiner
    Buti, Maria
    Pradat, Pierre
    Zoulim, Fabien
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (11) : 1882 - 1887
  • [33] Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo
    Lin, E
    Luscombe, C
    Colledge, D
    Wang, YY
    Locarnini, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2132 - 2137
  • [34] Hepatic fibrosis regression in hepatitis B Cohort on long-term oral antiviral therapy
    Verdon, C.
    Oh, S.
    Kiely, C.
    Hansen, R.
    Schramko, J.
    Pattullo, V.
    Jones, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 90 - 90
  • [35] LONG-TERM THERAPY OF CHRONIC HEPATITIS AND OF HEPATOCIRRHOSIS
    PUSCH, HJ
    ULLMANN, W
    MEDIZINISCHE KLINIK, 1975, 70 (15) : 674 - 681
  • [36] Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B
    Asselah, Tarik
    Marcellin, Patrick
    CLINICS IN LIVER DISEASE, 2013, 17 (03) : 445 - +
  • [37] The long-term course of chronic hepatitis B
    Di Marco, V
    Lo Iacono, O
    Cammà, C
    Vaccaro, A
    Giunta, M
    Martorana, G
    Fuschi, P
    Almasio, PL
    Craxì, A
    HEPATOLOGY, 1999, 30 (01) : 257 - 264
  • [38] Tenofovir-based antiviral therapy reduces long-term incidence of hepatocellular carcinoma in chronic hepatitis B patients
    Kim, W. Ray
    Lim, Young-Suk
    Janssen, Harry L. A.
    Ahn, Sang Hoon
    Jacobson, Ira
    Mizokami, Masashi
    Wong, Grace
    Abramov, Frida
    Yee, Leland J.
    Wang, Hongyuan
    Frenette, Catherine
    Flaherty, John F.
    Fung, Scott K.
    Marcellin, Patrick
    Seto, Wai-Kay
    Agarwal, Kosh
    Hou, Jinlin
    Lim, Seng Gee
    Kao, Jia-Horng
    Buti, Maria
    JOURNAL OF HEPATOLOGY, 2024, 80 : S797 - S797
  • [39] Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels
    Du, X.
    Wang, J.
    Shao, L.
    Hu, X.
    Yang, C.
    Shen, L.
    Weng, X.
    Zhang, W.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (05) : 328 - 335
  • [40] Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Huang, Rui
    Yan, Xiaomin
    Liu, Yong
    Zhang, Zhaoping
    Wu, Chao
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (09): : 1477 - 1478
12345